Editorial
Published on 25 Apr 2022
Editorial: Molecular Imaging in Multiple Myeloma: An Update and Future Perspectives
in PET and SPECT
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2022.904502
- 1,477 views
Type at least 3 characters
194 articles
articles
Original Research
Published on 14 Apr 2022
Cyclotrons Operated for Nuclear Medicine and Radiopharmacy in the German Speaking D-A-CH Countries: An Update on Current Status and Trends
in Radiopharmacy and Radiochemistry
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2022.850414
- 16,944 views
- 6 citations
Original Research
Published on 07 Apr 2022
Ki67 Immunohistochemical Expression Level ≥70%, Bulky Presentation ≥7.5 cm, Meningeal Lymphomatosis, and Interim PET ΔSUVmax After 4 Treatment Cycles <71% as Parts of a Practical Scoring System to Predict Progression-Free Survival and Overall Survival in Diffuse Large B-Cell Lymphoma
in PET and SPECT
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2022.829138
- 3,091 views
- 2 citations
Review
Published on 25 Mar 2022
The Application of in silico Methods for Prediction of Blood-Brain Barrier Permeability of Small Molecule PET Tracers
in Radiopharmacy and Radiochemistry
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2022.853475
- 11,021 views
- 35 citations
Review
Published on 21 Mar 2022
18F-FDG PET/CT Imaging: Normal Variants, Pitfalls, and Artifacts Musculoskeletal, Infection, and Inflammation
in PET and SPECT
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2022.847810
- 15,592 views
- 11 citations
Case Report
Published on 15 Mar 2022
Anti-thyroglobulin Antibodies as a Possible Risk Factor for Graves' Disease After Radioiodine Treatment for Toxic Nodular Goiter: Case Report
in Radionuclide Therapy
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2022.858062
- 3,620 views
- 2 citations
Review
Published on 08 Mar 2022
F-18 Fluoro-2-Deoxyglucose Positron Emission Tomography (PET)/Computed Tomography (CT) Imaging in Melanoma: Normal Variants, Pitfalls, and Artifacts
in PET and SPECT
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2022.835404
- 3,961 views
- 4 citations
Review
Published on 03 Mar 2022
Normal Variants and Pitfalls of 18F-FDG PET/CT Imaging in Pediatric Oncology
in PET and SPECT
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2022.825891
- 11,553 views
- 11 citations
Mini Review
Published on 25 Feb 2022
Molecular Imaging in Multiple Myeloma—Novel PET Radiotracers Improve Patient Management and Guide Therapy
in PET and SPECT
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2022.801792
- 3,608 views
- 6 citations
Review
Published on 22 Feb 2022
18F-FDG PET/CT and MRI in the Management of Multiple Myeloma: A Comparative Review
in PET and SPECT
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2021.808627
- 6,714 views
- 10 citations
Review
Published on 21 Feb 2022
Normal Variants, Pitfalls, and Artifacts in Ga-68 Prostate Specific Membrane Antigen (PSMA) PET/CT Imaging
in PET and SPECT
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2022.825512
- 29,188 views
- 16 citations
Case Report
Published on 16 Feb 2022
Case Report: Skeletal Muscle Lymphoma as a Result of Slow Centrifugal Migration of Untreated Primary Neurolymphomatosis?
in PET and SPECT
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2022.804421
- 2,300 views
Original Research
Published on 14 Feb 2022
Estimation of the Internal Dose Imparted by 18F-Fluorodeoxyglucose to Tissues by Using Fricke Dosimetry in a Phantom and Positron Emission Tomography
in Dosimetry and Radiation Safety
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2022.815141
- 5,005 views
- 2 citations
Review
Published on 07 Feb 2022
Normal Variants, Pitfalls and Artifacts in Ga-68 DOTATATE PET/CT Imaging
in PET and SPECT
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2022.825486
- 33,951 views
- 17 citations
Review
Published on 01 Feb 2022
Imaging Lymphoma With F-18 Fluorodeoxyglucose PET-CT: What Should Be Known About Normal Variants, Pitfalls, and Artifacts?
in Radionuclide Therapy
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2021.826046
- 9,950 views
- 4 citations
Review
Published on 21 Jan 2022
Shared Decision Making for Radioiodine Therapy and the Actual Pattern of Care in Intermediate-Risk Differentiated Thyroid Carcinoma
in Radionuclide Therapy
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2021.797522
- 2,732 views
- 1 citation
Original Research
Published on 20 Jan 2022
Synthesis of Radiopharmaceuticals via “In-Loop” 11C-Carbonylation as Exemplified by the Radiolabeling of Inhibitors of Bruton's Tyrosine Kinase
in Radiopharmacy and Radiochemistry
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2021.820235
- 6,785 views
- 11 citations
Review
Published on 17 Jan 2022
F-18 FDG PET/CT Imaging in Normal Variants, Pitfalls and Artifacts in the Abdomen and Pelvis
in PET and SPECT
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2021.826109
- 28,415 views
- 14 citations
Review
Published on 06 Jan 2022
Amino Acid and Proliferation PET/CT for the Diagnosis of Multiple Myeloma
in PET and SPECT
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2021.796357
- 3,120 views
- 3 citations
Case Report
Published on 14 Dec 2021
Case Report: Pleuropulmonary Blastoma in a 2.5-Year-Old Boy: 18F-FDG PET/CT Findings
in PET and SPECT
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2021.780485
- 3,539 views
- 5 citations
Original Research
Published on 13 Dec 2021
Optimization and Evaluation of Al18F Labeling Using a NOTA—or RESCA1-Conjugated AE105 Peptide Antagonist of uPAR
in Radiopharmacy and Radiochemistry
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2021.799533
- 4,238 views
- 4 citations
Original Research
Published on 30 Nov 2021
Clinical Outcomes After Radioiodine Therapy, According to the Method of Preparation by Recombinant TSH vs. Endogenous Hypothyroidism, in Thyroid Cancer Patients at Intermediate-High Risk of Recurrence
in Radionuclide Therapy
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2021.785768
- 2,962 views
- 3 citations
Original Research
Published on 18 Nov 2021
Fully Automated 68Ga-Labeling and Purification of Macroaggregated Albumin Particles for Lung Perfusion PET Imaging
in Radiopharmacy and Radiochemistry
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2021.778191
- 5,074 views
- 7 citations
![Radiosynthesis of [11C]Ibrutinib via Pd-Mediated [11C]CO Carbonylation: Preliminary PET Imaging in Experimental Autoimmune Encephalomyelitis Mice](https://www.frontiersin.org/files/myhome article library/772289/772289_Thumb_400.jpg)
Original Research
Published on 12 Nov 2021
Radiosynthesis of [11C]Ibrutinib via Pd-Mediated [11C]CO Carbonylation: Preliminary PET Imaging in Experimental Autoimmune Encephalomyelitis Mice
in Radiopharmacy and Radiochemistry
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2021.772289
- 3,417 views
- 10 citations